Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(14%)
Results Posted
33%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_2
1
14%
Ph phase_4
2
29%
Ph phase_1
1
14%
Ph not_applicable
3
43%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 4Post-market surveillance
2(28.6%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)
Other(2)

Detailed Status

Completed3
Active, not recruiting1
Terminated1
unknown1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (14.3%)
Phase 21 (14.3%)
Phase 42 (28.6%)
N/A3 (42.9%)

Trials by Status

active_not_recruiting114%
terminated114%
completed343%
unknown114%
suspended114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7